{"wiki_id": "http://www.wikidata.org/entity/Q2075967", "itemLabel": "Peter J. Ratcliffe", "itemDescription": "British biologist & Nobel laureate in medicine", "wikipedia_url": "https://en.wikipedia.org/wiki/Peter_J._Ratcliffe", "wikipedia_page": {"main": "Sir Peter John Ratcliffe, FRS, FMedSci (born 14 May 1954) is a British Nobel Laureate physician-scientist who is trained as a nephrologist. He was a practising clinician at the John Radcliffe Hospital, Oxford and Nuffield Professor of Clinical Medicine and head of the Nuffield Department of Clinical Medicine at the University of Oxford from 2004 to 2016. He has been a Fellow of Magdalen College, Oxford since 2004. In 2016 he became Clinical Research Director at the Francis Crick Institute, retaining a position at Oxford as member of the Ludwig Institute of Cancer Research and Director of the Target Discovery Institute, University of Oxford.Ratcliffe is best known for his work on cellular reactions to hypoxia, for which he shared the 2019 Nobel Prize in Physiology or Medicine with William Kaelin Jr. and Gregg L. Semenza.", "link_mentions": [{"page": "1954", "response": ["** Peter J. Ratcliffe, English cellular biologist, Nobel Prize laureate"]}, {"page": "2019", "response": ["* Physiology or Medicine \u2013 William Kaelin Jr., Peter J. Ratcliffe, and Gregg L. Semenza"]}, {"page": "Magdalen College, Oxford", "response": ["Sir Peter J. Ratcliffe held the Nuffield Professorship of Clinical Medicine between 2003 and 2006, and is still a supernumerary fellow at Magdalen. He shared the 2019 Nobel Prize in Physiology or Medicine for his work on the oxygen sensing of cells. Other former Nuffield Professors of Clinical Medicine include Sir David Weatherall, who founded the Weatherall Institute of Molecular Medicine in 1989, and Sir John Bell GBE, who is also an alumnus of the college. The current holder of the chair is Richard Cornall, who was appointed in 2019."]}, {"page": "Erythropoietin", "response": ["Gregg L. Semenza and Peter J. Ratcliffe studied the EPO gene and its oxygen-dependent regulation. Along with William Kaelin Jr., they were awarded the 2019 Nobel Prize in Physiology or Medicine for their discovery of hypoxia-inducible factor (HIF), which regulates the EPO gene, as well as other genes, in response to hypoxia."]}]}}